The Role of NADPH Oxidase in Leukocyte-endothelial Interactions in Rat Mesenteric
Postcapillary Venules
Hung Pham, Amber N. Koon, Brian Rueter, Lindon H. Young, Qian Chen
Department of Pathology, Microbiology, Immunology & Forensic Medicine, Philadelphia College of Osteopathic Medicine

Introduction

Methods

Inflammatory responses following vascular endothelial dysfunction have been
considered critical and initial steps leading to the pathogenesis of many diseases,
such as hypertension, ischemia/reperfusion (I/R) injury, and vascular complications
in diabetes. Endothelial dysfunction is characterized by increase in reactive oxygen
species (ROS) and decrease in endothelial-derived nitric oxide (NO). Under normal
physiological conditions, endothelial-derived NO is produced via endothelial NO
synthase (eNOS) and is a key component of vascular homeostasis responsible for
regulating normal blood pressure, vasodilation, anti-inflammatory responses, and
anti-coagulation properties. It has been shown that decrease in NO bioavailability
by NG-nitro-L-arginine-methyl-ester (L-NAME), a non-selective NOS inhibitor,
can induce inflammatory responses (1). On the other hand, vascular endothelial
NADPH oxidase produces ROS normally at small quantity for the purposes of
signaling transduction and cellular regulation. However, during pathological
conditions, NO bioavailability is decreased and leukocyte NADPH oxidase is
activated via assembly of its subunits on the cell membrane resulting in
overproduction of superoxide (SO) and subsequent hydrogen peroxide (H2O2)
release and leading to oxidative stress. Furthermore, SO can directly react with NO
to produce peroxynitrite (ONOO-) and thereby decreases NO bioavailability,
exacerbates endothelial dysfunction, and subsequently initiates leukocyteendothelial interactions. Therefore, the recruitment of leukocytes will amplify the
inflammatory responses and lead to tissue and organ damage. However, it is still
unclear of the role of NADPH oxidase in leukocyte-endothelial under basal level
and activated status during inflammatory responses. In this study, two NADPH
oxidase inhibitors, apocynin and Gp91 ds-tat will be tested on basal and L-NAME
induced leukocyte-endothelial interactions. Apocynin or Gp91 ds-tat, prevent the
assembly of catalytic subunits of the enzyme and thereby inhibit SO release from
NADPH oxidase as shown in figure 1 (2-4).

Intravital microscopy
Male Sprague-Dawley rats, weighing 275-325 g, were anesthetized with 60 mg/kg
pentobarbital sodium intraperitoneally (i.p.) and maintained with 30 mg/kg
pentobarbital sodium (i.p.). The left carotid was isolated and cannulated to monitor
the mean arterial blood pressure (MABP). A loop of the ileal mesentery was
exteriorized via midline laparotomy and superfused with physiological buffer (i.e.
Krebs’ buffer) or Krebs’ buffer with different treatments (Table 1). After 30 min
stabilization, Leukocyte-endothelial interactions within the mesenteric postcapillary
venules were observed via intravital microscopy for 2 hr. After the experiment,
mesenteric tissue was harvested for hematoxylin and eosin (H&E) staining to
evaluate leukocyte adherence and transmigration. All data is represented as means
± standard error of the mean (SEM). The comparison of more than two groups was
analyzed by ANOVA using post hoc analysis with the Bonferroni/Dunn test to
detect differences among experimental groups with each aim. Probability values of
<0.05 are considered to be statistically significant.

Figure 5. Leukocyte transmigration among different experimental groups. 50 µM
L-NAME significantly increased leukocyte transmigration at T=60, 90, and 120
min (**P<0.01 from Krebs’). The effect of L-NAME was significantly attenuated
by the administration of 40 μM or 400 µM apocynin at T=60, 90, &120 min (left
panel) and 20 µM Gp91 ds-tat at T=90 & 120 min (right panel) (##P<0.01 from
L-NAME).
Figure 2. Experimental setup for intravital microscopy. Inserted picture upper right:
exteriorized loop of mesenteric tissue undergoing superfusion of test solution.
Table 1. Experimental Groups
1. Control (n=6)
superfusion of Krebs’ buffer
2-3. Apocynin (n=5-7)
superfusion of 400 µM/ 1000 µM in Krebs’ buffer
4. L-NAME (n=5)
superfusion of 50 µM L-NAME
5-7. L-NAME+Apocynin superfusion of 50 µM L-NAME with 40 µM/ 400
(n=6-7)
µM/ 1000 µM apocynin
8-9 L-NAME+Gp91 ds-tat superfusion of 50 µM L-NAME with 5 µM/ 20 µM
(n=4-6)
Gp91 ds-tat

Results
Figure 1. Apocynin and Gp91 ds-tat inhibit the assembly of catalytic subunits of
NADPH oxidase. Apocynin inhibits the translocation of p47phox along with other
cytosolic subunits (p67phox and p40phox) to the membranous subunits (gp91phox
and p22phox). Gp91 ds-tat contains gp91phox docking sequence, which binds to
p47phox and prevents the interaction of p47phox with gp91phox and thereby
inhibits the assembly of NADPH oxidase. Adapted and modified from Brandes RP
2003 (2).

Hypothesis

Figure 4. Leukocyte adherence among different experimental groups. 50 µM LNAME significantly increased leukocyte adherence at T=60, 90, and 120 min
(**P<0.01 from Krebs’). The effect of L-NAME was significantly attenuated by
the administration of 40 μM or 400 µM apocynin at T=60, 90, &120 min (left
panel) and 20 µM Gp91 ds-tat at T=90 & 120 min (right panel) (##P<0.01 from
L-NAME).

Figure 3. Leukocyte rolling among different experimental groups. 50 µM L-NAME
We hypothesized that L-NAME treatment will induce leukocyte-endothelial significantly increased leukocyte rolling at T=90 min and T=120 min (**P<0.01
interactions. Furthermore, apocynin will not influence basal leukocyte-endothelial from Krebs’). The effect of L-NAME was significantly attenuated by the
interactions. Moreover, apocynin or Gp91ds-tat will dose-dependently attenuate L- administration of 40 μM or 400 µM apocynin at T=60, 90, &120 min (left panel)
and 20 µM Gp91 ds-tat at T=90 & 120min (right panel) (##P<0.01 from L-NAME).
NAME induced leukocyte-endothelial interactions.
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Figure 6. Representative pictures (20x) of leukocytes by H&E staining of
mesenteric tissue from Krebs’ control (A), L-NAME (B), L-NAME+ 400 µM
apocynin (C), L-NAME+ 20 µM Gp91 ds-tat (D). L-NAME treatment exhibited a
marked increase in leukocyte vascular adherence and transmigration compared to
Krebs’ buffer. By contrast, apocynin or Gp91 ds-tat exhibited a marked decrease
in adherent and transmigrated leukocytes compared to L-NAME. Black arrow
indicates adherence and red arrow indicate transmigration (scale bar: 20 μm).

Conclusions
L-NAME treatment significantly increased leukocyte-endothelial interactions
compared to the Krebs’ buffer control (p<0.01). Apocynin had less influence on
basal leukocyte-endothelial interactions. However, apocynin or Gp91 ds-tat dosedependently attenuated L-NAME induced leukocyte-endothelial interactions with
time (p<0.01). High dose of apocynin (1000 µM) suggested that apocynin exerted
inflammatory responses independent of inhibition of NADPH oxidase. The results
suggested that inhibiting the assembly of NAPDH oxidase is an important
mechanism to attenuate leukocyte-endothelial interactions induced by endothelial
dysfunction. Therefore, NADPH oxidase inhibitors may be beneficial to mitigate
the pathogenesis of inflammatory-mediated vascular diseases.
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